Breast cancer: Why it's difficult to treat and what new approaches are on the horizon
Breast cancer is the number one cancer among women: more than 2 million cases were diagnosed worldwide in 2022. It is also ...
AllAfrica.com11h
Africa: Breast Cancer - Why It's Difficult to Treat and What New Approaches Are On the Horizon
Analysis - Breast cancer is the number one cancer among women: more than 2 million cases were diagnosed worldwide in 2022. It ...
eLife12h
Membrane potential modulates ERK activity and cell proliferation
Department of Physiology, Division of Life Science, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan ...
birmingham.ac.uk14h
Study charts course for next generation of drug targets in autoimmune diseases
In a world first, researchers have mapped the cellular dynamics following treatment with the most commonly used advanced ...
eLife1d
Subtypes and proliferation patterns of small intestine neuroendocrine tumors revealed by single cell RNA sequencing
Endocrine Neoplasia Translational Research Center, Division of Endocrinology, Diabetes and Metabolism, Chaim Sheba Medical Center, and Tel Aviv University Faculty of Medicine, Ramat Gan, Israel This ...
FierceBiotech4d
GSK and Boston scientists team up to study pulmonary fibrosis and develop new treatments
London-based GSK is crossing the pond to form a new lung disease research collaboration with Boston scientists. | ...
Medscape4d
EMA Authorizes Korjuny for Malignant Ascites
The European Medicines Agency has recommended Korjuny for the treatment of patients with intraperitoneal malignant ascites.
News Medical on MSN5d
Boston University and GSK collaborate to tackle pulmonary fibrosis
Researchers from the Center for Regenerative Medicine (CReM) at Boston University and Boston Medical Center (BMC) have ...
FierceBiotech5d
Compounds from healthy vaginal bacteria show promise as inflammation treatment
Just as Smita Gopinath, Ph.D., was setting up her microbiology and immunology lab at Harvard T.H. Chan School of Public ...
Defective Mitochondria: New Research Uncovers Hidden Cause of Crohn’s Disease
Researchers at the Technical University of Munich (TUM) have linked mitochondrial dysfunctions to Crohn’s disease, ...
EurekAlert!6d
BU, Boston Medical Center researchers join forces with GSK to fight lung diseases
Researchers from the Center for Regenerative Medicine at Boston University and Boston Medical Center have announced a new collaboration with the global biopharma company GSK to advance innovative ...